Consternation as Congress proposal for autonomous prescribing AI coincides with the haphazard cuts at the FDA.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40102664.
- Also identified by DOI 10.1038/s41746-025-01540-2 and PMC identifier 11920405.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We live in interesting regulatory times. In January, a bill was introduced to the US Congress proposing that AI “can qualify as a practitioner eligible to prescribe drugs” if overseen by the States and FDA. This a bold and contentious move. Even proponents of AI’s swift integration into medicine must recognize the deep paradox: this proposal emerges even as the FDA’s world-leading infrastructure for AI oversight faces dismantling.